S 2212
115th Congress
Senate
Health
Administrative law and regulatory procedures
Aging
Appropriations
Budget deficits and national debt
Cancer
Child health
Computers and information technology
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Education programs funding
Environmental health
Executive agency funding and structure
Food and Drug Administration (FDA)
Genetics
Government trust funds
Health care costs and insurance
Health information and medical records
Health personnel
National Biomedical Research Act
Introduced: December 7, 2017
Introduced by:
Warren, Elizabeth
Democratic
· Massachusetts
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 7, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 7, 2017
Introduced in Senate
Plain-English summary
National Biomedical Research Act
This bill establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative research.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1